Rapport Therapeutics IPO Shares Open For Trade At $18/Share; ; IPO Priced At $17 On 8M Shares
Portfolio Pulse from Benzinga Newsdesk
Rapport Therapeutics IPO shares opened for trade at $18 per share, after being priced at $17 on 8 million shares.
June 07, 2024 | 3:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rapport Therapeutics IPO shares opened at $18 per share, higher than the IPO price of $17 on 8 million shares.
The opening price of $18 per share, which is higher than the IPO price of $17, indicates strong initial demand and positive market sentiment. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100